首页 > 最新文献

Molecular Metabolism最新文献

英文 中文
Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept Eloralintide (LY3841136),一种治疗肥胖的新型胰肽受体激动剂:从发现到临床概念证明。
IF 6.6 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-16 DOI: 10.1016/j.molmet.2025.102271
Daniel A. Briere, Hongchang Qu, Katherine Lansu, Minxia Michelle He, Julie S. Moyers, Tamer Coskun, Annie Long, Dawn Allen, Libbey O'Farrell, Breanna Bowen, Edward Pratt, Beth Tidemann-Miller, Lai San Tham, Hilda Ibriga, Jorge Alsina-Fernandez, Kieren J. Mather, Axel Haupt, Shobha N. Bhattachar

Objectives

Eloralintide (LY3841136), a novel amylin analog, was evaluated in translational studies to characterize its therapeutic potential for treating obesity.

Methods

In vitro assays were performed in cell lines selectively expressing rat or human amylin 1 receptor (AMY1R), amylin 3 receptor (AMY3R), or calcitonin receptor (CTR). In vivo studies were conducted in rats and monkeys. A phase 1, randomized, placebo-controlled, participant/investigator-blinded trial evaluated the safety and tolerability of single-ascending eloralintide doses (0.04–12 mg) in healthy participants (NCT05295940).

Results

In vitro, eloralintide preferentially activated human AMY1R (12-fold > CTR, 11-fold > AMY3R), while in rats, both AMY1R and AMY3R were activated more potently than CTR. Eloralintide induced significantly less conditioned taste avoidance in lean rats than cagrilintide, a non-selective amylin receptor agonist (p < 0.05). Eloralintide dose dependently reduced food intake and lowered body weight, primarily through fat mass loss, in diet-induced obese rats. Eloralintide demonstrated favorable pharmacokinetics in both rats and monkeys. In the phase 1 trial, 48 healthy participants had a mean body mass index of 27.5 kg/m2. Nine participants in the eloralintide cohorts reported 16 adverse events, with most being mild (n = 15/16). Two participants reported 4 gastrointestinal events, including one moderate vomiting event. The pharmacokinetic profile of eloralintide supports once-weekly dosing. In eloralintide cohorts receiving single doses of 4 or 12 mg, week-4 mean percent change from baseline in body weight was −2.5% (p < 0.01) and −4.4% (p < 0.001), respectively, vs placebo (+0.6%).

Conclusions

Once-weekly dosing with eloralintide, an AMY1R-selective agonist, may offer a promising new therapeutic with favorable gastrointestinal tolerability for the treatment of obesity.
目的:Eloralintide (LY3841136)是一种新型的amylin类似物,在转化研究中评估其治疗肥胖的潜力。方法:选择表达大鼠或人amylin 1受体(AMY1R)、amylin 3受体(AMY3R)或降钙素受体(CTR)的细胞系进行体外检测。在老鼠和猴子身上进行了体内研究。一项1期、随机、安慰剂对照、参与者/研究者盲法试验评估了健康参与者(NCT05295940)单次提升埃洛拉肽剂量(0.04-12 mg)的安全性和耐受性。结果:在体外,eloralintide优先激活人AMY1R(12倍> CTR, 11倍> AMY3R),而在大鼠中,AMY1R和AMY3R的激活都比CTR更有效。Eloralintide比cagrilintide(一种非选择性的淀粉酶受体激动剂)在瘦肉大鼠中诱导的条件性味觉回避明显减少。eloralintide组的9名参与者报告了16起不良事件,其中大多数是轻微的(n=15/16)。两名参与者报告了4次胃肠道事件,包括一次中度呕吐事件。依洛林肽的药代动力学特征支持每周给药一次。在接受单剂量4或12mg的eloralintide队列中,第4周体重与基线相比的平均变化百分比为-2.5%(结论:每周一次服用eloralintide,一种amy1r选择性激动剂,可能为治疗肥胖提供了一种有希望的新疗法,具有良好的胃肠道耐受性。
{"title":"Eloralintide (LY3841136), a novel amylin receptor agonist for the treatment of obesity: From discovery to clinical proof of concept","authors":"Daniel A. Briere,&nbsp;Hongchang Qu,&nbsp;Katherine Lansu,&nbsp;Minxia Michelle He,&nbsp;Julie S. Moyers,&nbsp;Tamer Coskun,&nbsp;Annie Long,&nbsp;Dawn Allen,&nbsp;Libbey O'Farrell,&nbsp;Breanna Bowen,&nbsp;Edward Pratt,&nbsp;Beth Tidemann-Miller,&nbsp;Lai San Tham,&nbsp;Hilda Ibriga,&nbsp;Jorge Alsina-Fernandez,&nbsp;Kieren J. Mather,&nbsp;Axel Haupt,&nbsp;Shobha N. Bhattachar","doi":"10.1016/j.molmet.2025.102271","DOIUrl":"10.1016/j.molmet.2025.102271","url":null,"abstract":"<div><h3>Objectives</h3><div>Eloralintide (LY3841136), a novel amylin analog, was evaluated in translational studies to characterize its therapeutic potential for treating obesity.</div></div><div><h3>Methods</h3><div>In vitro assays were performed in cell lines selectively expressing rat or human amylin 1 receptor (AMY1R), amylin 3 receptor (AMY3R), or calcitonin receptor (CTR). In vivo studies were conducted in rats and monkeys. A phase 1, randomized, placebo-controlled, participant/investigator-blinded trial evaluated the safety and tolerability of single-ascending eloralintide doses (0.04–12 mg) in healthy participants (NCT05295940).</div></div><div><h3>Results</h3><div>In vitro, eloralintide preferentially activated human AMY1R (12-fold &gt; CTR, 11-fold &gt; AMY3R), while in rats, both AMY1R and AMY3R were activated more potently than CTR. Eloralintide induced significantly less conditioned taste avoidance in lean rats than cagrilintide, a non-selective amylin receptor agonist (p &lt; 0.05). Eloralintide dose dependently reduced food intake and lowered body weight, primarily through fat mass loss, in diet-induced obese rats. Eloralintide demonstrated favorable pharmacokinetics in both rats and monkeys. In the phase 1 trial, 48 healthy participants had a mean body mass index of 27.5 kg/m<sup>2</sup>. Nine participants in the eloralintide cohorts reported 16 adverse events, with most being mild (n = 15/16). Two participants reported 4 gastrointestinal events, including one moderate vomiting event. The pharmacokinetic profile of eloralintide supports once-weekly dosing. In eloralintide cohorts receiving single doses of 4 or 12 mg, week-4 mean percent change from baseline in body weight was −2.5% (p &lt; 0.01) and −4.4% (p &lt; 0.001), respectively, vs placebo (+0.6%).</div></div><div><h3>Conclusions</h3><div>Once-weekly dosing with eloralintide, an AMY1R-selective agonist, may offer a promising new therapeutic with favorable gastrointestinal tolerability for the treatment of obesity.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"102 ","pages":"Article 102271"},"PeriodicalIF":6.6,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145318511","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interaction between time-of-day and oxytocin efficacy in mice and humans with and without gestational diabetes 在有和没有妊娠糖尿病的小鼠和人类中,时间和催产素功效之间的相互作用。
IF 6.6 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-16 DOI: 10.1016/j.molmet.2025.102269
Thu Van-Quynh Duong , Alexandra M. Yaw , Guoli Zhou , Niharika Sinha , Aneesh Sai Cherukuri , Duong Nguyen , Kylie Cataldo , Nicollette Ly , Aritro Sen , Lorenzo F. Sempere , Cara Detrie , Robert Seiler , I. Nicholas Olomu , Rene Cortese , Robert Long , Hanne M. Hoffmann
Due to significant risks of peripartum complications, pregnancies complicated by diabetes often require labor induction or augmentation with synthetic oxytocin. However, the efficacy of oxytocin is often compromised in diabetic pregnancies. Given that diabetes deregulates the body's circadian timekeeping system, our objective was to determine how time of day and the circadian clock gene, Bmal1, gate oxytocin efficacy. We compared oxytocin uterotonic efficacy in a smooth muscle-Bmal1 conditional knockout mouse (cKO), and a mouse model of food-induced gestational diabetes. We found that in wild-type mice, the oxytocin receptor is expressed in a time-of-day-dependent manner and is under the control of BMAL1. Both Bmal1 cKO and food-induced gestational diabetes mice, which presented with a downregulation of Bmal1 in the uterus, had decreased uterine contractility in response to oxytocin. To establish the translational value of these findings, we utilized an immortalized term human myometrial cell line. We determined that the time-of-day impacted oxytocin-induced myometrial contractility in vitro. Furthermore, we conducted a retrospective medical record analysis of 2,367 pregnant patients ≥39 weeks gestation undergoing induction of labor. We assessed the timing of labor induction and the impact of gestational diabetes mellitus on labor duration. Induction of labor in the morning compared to midnight was associated with a ∼1.5-hour and ∼7-hour shorter labor duration in controls and patients with gestational diabetes mellitus, respectively. In conclusion, circadian timing plays a key role in induction of labor and oxytocin responsiveness and should be considered when managing labor induction.
由于围产期并发症的显著风险,合并糖尿病的妊娠通常需要引产或人工合成催产素增强。然而,在糖尿病孕妇中,催产素的功效经常受到损害。鉴于糖尿病解除了人体的昼夜节律计时系统,我们的目标是确定一天中的时间和昼夜节律时钟基因Bmal1如何影响催产素的功效。我们比较了催产素在平滑肌- bmal1条件敲除小鼠(cKO)和食物性妊娠糖尿病小鼠模型中的子宫张力效果。我们发现,在野生型小鼠中,催产素受体以一种时间依赖性的方式表达,并受BMAL1的控制。Bmal1 cKO和食物诱导的妊娠糖尿病小鼠,子宫Bmal1表达下调,在催产素的作用下,子宫收缩能力下降。为了确定这些发现的转化价值,我们利用了一个不朽的人子宫内膜细胞系。我们确定一天中的时间影响催产素诱导的子宫肌收缩力。此外,我们对2367例妊娠≥39周引产的孕妇进行了回顾性病历分析。我们评估引产时机和妊娠期糖尿病对分娩时间的影响。在对照组和妊娠期糖尿病患者中,早晨引产与午夜引产相比,分别缩短了~ 1.5小时和~ 7小时的产程。总之,昼夜节律在引产和催产素反应中起着关键作用,在引产时应考虑到这一点。
{"title":"Interaction between time-of-day and oxytocin efficacy in mice and humans with and without gestational diabetes","authors":"Thu Van-Quynh Duong ,&nbsp;Alexandra M. Yaw ,&nbsp;Guoli Zhou ,&nbsp;Niharika Sinha ,&nbsp;Aneesh Sai Cherukuri ,&nbsp;Duong Nguyen ,&nbsp;Kylie Cataldo ,&nbsp;Nicollette Ly ,&nbsp;Aritro Sen ,&nbsp;Lorenzo F. Sempere ,&nbsp;Cara Detrie ,&nbsp;Robert Seiler ,&nbsp;I. Nicholas Olomu ,&nbsp;Rene Cortese ,&nbsp;Robert Long ,&nbsp;Hanne M. Hoffmann","doi":"10.1016/j.molmet.2025.102269","DOIUrl":"10.1016/j.molmet.2025.102269","url":null,"abstract":"<div><div>Due to significant risks of peripartum complications, pregnancies complicated by diabetes often require labor induction or augmentation with synthetic oxytocin. However, the efficacy of oxytocin is often compromised in diabetic pregnancies. Given that diabetes deregulates the body's circadian timekeeping system, our objective was to determine how time of day and the circadian clock gene, <em>Bmal1</em>, gate oxytocin efficacy. We compared oxytocin uterotonic efficacy in a smooth muscle-<em>Bmal1</em> conditional knockout mouse (cKO), and a mouse model of food-induced gestational diabetes. We found that in wild-type mice, the oxytocin receptor is expressed in a time-of-day-dependent manner and is under the control of BMAL1. Both <em>Bmal1</em> cKO and food-induced gestational diabetes mice, which presented with a downregulation of <em>Bmal1</em> in the uterus, had decreased uterine contractility in response to oxytocin. To establish the translational value of these findings, we utilized an immortalized term human myometrial cell line. We determined that the time-of-day impacted oxytocin-induced myometrial contractility <em>in vitro</em>. Furthermore, we conducted a retrospective medical record analysis of 2,367 pregnant patients ≥39 weeks gestation undergoing induction of labor. We assessed the timing of labor induction and the impact of gestational diabetes mellitus on labor duration. Induction of labor in the morning compared to midnight was associated with a ∼1.5-hour and ∼7-hour shorter labor duration in controls and patients with gestational diabetes mellitus, respectively. In conclusion, circadian timing plays a key role in induction of labor and oxytocin responsiveness and should be considered when managing labor induction.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"103 ","pages":"Article 102269"},"PeriodicalIF":6.6,"publicationDate":"2025-10-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145318456","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Beta cell secreted GABA sets appropriate insulin secretion by modulating islet calcium oscillations β细胞分泌的GABA通过调节胰岛钙振荡来调节胰岛素分泌。
IF 6.6 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-15 DOI: 10.1016/j.molmet.2025.102268
Sandra M. Ferreira , D. Walker Hagan , Austin E. Stis , Adrienne E. Widener , Alexandra E. Cuaycal , Chad Rancourt , Arabella G. Readey , Dylan S. Smurlick , Dongtao A. Fu , Martha Campbell–Thompson , Marjan Slak Rupnik , Edward A. Phelps

Objectives

Gamma-aminobutyric acid (GABA) is produced in pancreatic beta cells and is implicated in modulating islet function, yet its precise physiological role remains uncertain. This study aimed to determine the function of endogenous beta cell-derived GABA on insulin secretion and islet calcium dynamics by developing a conditional beta cell-specific knockout of GABA-synthesizing enzymes (GAD65 and GAD67).

Methods

Conditional knockout mice (Gad βKO) lacking both GAD65 and GAD67 specifically in pancreatic beta cells were generated. Glucose-stimulated insulin secretion was measured in isolated islets and in vivo and islet Ca2+ oscillations were recorded using calcium imaging. The effects of GABA and its receptor agonists/antagonists were tested under various glucose conditions. Additional analyses were performed in high-fat diet-fed mice and human islets from donors with and without type 2 diabetes (T2D).

Results

Gad βKO islets were devoid of GABA and showed excessive insulin secretion in response to glucose without anatomical changes in islet composition. These islets had defective Ca2+ oscillations, with prolonged active phases and reduced amplitudes. GABA application suppressed Ca2+ oscillations, an effect mediated by GABAA and GABAB receptors. High-fat diet-fed and T2D human islets were unresponsive to GABA and exhibited impaired Ca2+ oscillations.

Conclusions

This is the first study using a beta cell-specific GAD65/GAD67 knockout model. Endogenous beta cell-derived GABA is critical for modulating insulin secretion by maintaining proper Ca2+ oscillation dynamics. GABA signaling likely operates as a delayed negative feedback mechanism that reinforces oscillatory homeostasis in islets. The loss of GABA responsiveness, as seen in metabolic stress or T2D, may contribute to islet dysfunction. This work establishes GABA as a key regulator of islet rhythm and glucose responsiveness.
目的:γ -氨基丁酸(GABA)在胰腺β细胞中产生,并参与调节胰岛功能,但其确切的生理作用尚不清楚。本研究旨在通过开发条件β细胞特异性敲除GABA合成酶(GAD65和GAD67)来确定内源性β细胞来源的GABA对胰岛素分泌和胰岛钙动力学的功能。方法:制备胰β细胞特异性缺乏GAD65和GAD67的条件敲除小鼠(GadβKO)。在离体胰岛中测量葡萄糖刺激的胰岛素分泌,并使用钙成像记录体内和胰岛Ca2+振荡。测试了GABA及其受体激动剂/拮抗剂在不同葡萄糖条件下的作用。在高脂肪饮食喂养的小鼠和来自2型糖尿病(T2D)和非2型糖尿病(T2D)供体的人胰岛中进行了额外的分析。结果:gadβ - ko胰岛缺乏GABA,在葡萄糖的作用下表现出过量的胰岛素分泌,但胰岛结构没有改变。这些胰岛有缺陷的Ca2+振荡,具有延长的活跃阶段和降低的幅度。GABA的应用抑制Ca2+振荡,GABAA和GABAB受体介导的作用。高脂肪饮食喂养和T2D人胰岛对GABA无反应,并表现出受损的Ca2+振荡。结论:这是首次使用β细胞特异性GAD65/GAD67敲除模型的研究。内源性β细胞衍生的GABA是通过维持适当的Ca2+振荡动力学来调节胰岛素分泌的关键。GABA信号可能是一种延迟的负反馈机制,加强了胰岛的振荡稳态。代谢应激或T2D中GABA反应性的丧失可能导致胰岛功能障碍。这项工作确定了GABA是胰岛节律和葡萄糖反应性的关键调节因子。
{"title":"Beta cell secreted GABA sets appropriate insulin secretion by modulating islet calcium oscillations","authors":"Sandra M. Ferreira ,&nbsp;D. Walker Hagan ,&nbsp;Austin E. Stis ,&nbsp;Adrienne E. Widener ,&nbsp;Alexandra E. Cuaycal ,&nbsp;Chad Rancourt ,&nbsp;Arabella G. Readey ,&nbsp;Dylan S. Smurlick ,&nbsp;Dongtao A. Fu ,&nbsp;Martha Campbell–Thompson ,&nbsp;Marjan Slak Rupnik ,&nbsp;Edward A. Phelps","doi":"10.1016/j.molmet.2025.102268","DOIUrl":"10.1016/j.molmet.2025.102268","url":null,"abstract":"<div><h3>Objectives</h3><div>Gamma-aminobutyric acid (GABA) is produced in pancreatic beta cells and is implicated in modulating islet function, yet its precise physiological role remains uncertain. This study aimed to determine the function of endogenous beta cell-derived GABA on insulin secretion and islet calcium dynamics by developing a conditional beta cell-specific knockout of GABA-synthesizing enzymes (GAD65 and GAD67).</div></div><div><h3>Methods</h3><div>Conditional knockout mice (<em>Gad</em> <sup>βKO</sup>) lacking both GAD65 and GAD67 specifically in pancreatic beta cells were generated. Glucose-stimulated insulin secretion was measured in isolated islets and <em>in vivo</em> and islet Ca<sup>2+</sup> oscillations were recorded using calcium imaging. The effects of GABA and its receptor agonists/antagonists were tested under various glucose conditions. Additional analyses were performed in high-fat diet-fed mice and human islets from donors with and without type 2 diabetes (T2D).</div></div><div><h3>Results</h3><div><em>Gad</em> <sup>βKO</sup> islets were devoid of GABA and showed excessive insulin secretion in response to glucose without anatomical changes in islet composition. These islets had defective Ca<sup>2+</sup> oscillations, with prolonged active phases and reduced amplitudes. GABA application suppressed Ca<sup>2+</sup> oscillations, an effect mediated by GABA<sub>A</sub> and GABA<sub>B</sub> receptors. High-fat diet-fed and T2D human islets were unresponsive to GABA and exhibited impaired Ca<sup>2+</sup> oscillations.</div></div><div><h3>Conclusions</h3><div>This is the first study using a beta cell-specific GAD65/GAD67 knockout model. Endogenous beta cell-derived GABA is critical for modulating insulin secretion by maintaining proper Ca<sup>2+</sup> oscillation dynamics. GABA signaling likely operates as a delayed negative feedback mechanism that reinforces oscillatory homeostasis in islets. The loss of GABA responsiveness, as seen in metabolic stress or T2D, may contribute to islet dysfunction. This work establishes GABA as a key regulator of islet rhythm and glucose responsiveness.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"102 ","pages":"Article 102268"},"PeriodicalIF":6.6,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145313216","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Dimorphic regulation of time-restricted feeding effects by hepatocyte Period 1 肝细胞周期对限时摄食效应的二态调节。
IF 6.6 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-15 DOI: 10.1016/j.molmet.2025.102270
Jiameng Sun , Cassandra B. Higgins , Joshua A. Adams , Yiming Zhang , Shannon C. Kelly , Hyo-Jin Kim , Brian J. DeBosch

Objectives

Obesity is linked to metabolic disorders including type 2 diabetes, metabolic dysfunction-associated steatotic liver disease, and cardiovascular disease. Lifestyle interventions, such as time-restricted feeding (TRF), have proven to be effective for long-term weight management. The metabolic effects of TRF are closely associated with circadian clock function in the liver. We previously demonstrated that the circadian gene Period 1 (Per1) mediates responses to acute fasting in both sexes. We therefore hypothesized that hepatocyte Per1 contributes to the long-term adaptations to repeated fasting exposure in the form of TRF, and investigated its role in diet-induced obesity in both sexes.

Methods

Male and female mice with or without hepatocyte Per1 (Per1fl/fl and Per1LKO) were subjected to either ad libitum feeding (ALF) or TRF restricted to the active phase (8 h/day).

Results

TRF attenuated Western diet-induced weight gain and peripheral and hepatic lipid accumulation, and improved heat production, metabolic substrate flexibility, and glucose homeostasis in Per1fl/fl and Per1LKO males. In contrast, hepatocyte Per1 was required for TRF-induced improvements in energy expenditure and peripheral and hepatic lipid accumulation in females. Surprisingly, TRF failed to significantly attenuate diet-induced weight gain or glucose and insulin tolerance in females independent of genotype. Transcriptomic data revealed sex-specific transcriptional responses to TRF and to hepatocyte-specific Per1 deletion. Specifically, genes involved in lipid metabolism were differentially regulated when comparing TRF-treated Per1fl/fl and Per1LKO female mice.

Conclusions

Hepatocyte Per1 mediates the energy, lipid, and glucose homeostatic effects of TRF, and this regulation is almost completely sex-dependent.
目的:肥胖与代谢性疾病有关,包括2型糖尿病、代谢性功能障碍相关的脂肪变性肝病和心血管疾病。生活方式干预,如限时喂养(TRF),已被证明对长期体重管理是有效的。TRF的代谢作用与肝脏的生物钟功能密切相关。我们之前已经证明,昼夜节律基因周期1 (Per1)介导了两性对急性禁食的反应。因此,我们假设肝细胞Per1以TRF的形式参与了对反复禁食暴露的长期适应,并研究了其在两性饮食性肥胖中的作用。方法:将有或没有肝细胞Per1 (Per1fl/fl和Per1LKO)的雄性和雌性小鼠分别进行自由喂养(ALF)或限制在活动期(8 h/d)的TRF。结果:TRF减轻了西方饮食引起的体重增加和外周和肝脏脂质积累,改善了Per1fl/fl和Per1LKO男性的产热、代谢底物灵活性和葡萄糖稳态。相比之下,肝细胞Per1是trf诱导的女性能量消耗和外周及肝脏脂质积累改善所必需的。令人惊讶的是,与基因型无关,TRF未能显著减轻饮食引起的体重增加或女性的葡萄糖和胰岛素耐受性。转录组学数据揭示了对TRF和肝细胞特异性Per1缺失的性别特异性转录反应。具体来说,在比较trf处理的Per1fl/fl和Per1LKO雌性小鼠时,参与脂质代谢的基因受到了不同的调节。结论:肝细胞Per1介导TRF的能量、脂质和葡萄糖稳态作用,这种调节几乎完全是性别依赖的。
{"title":"Dimorphic regulation of time-restricted feeding effects by hepatocyte Period 1","authors":"Jiameng Sun ,&nbsp;Cassandra B. Higgins ,&nbsp;Joshua A. Adams ,&nbsp;Yiming Zhang ,&nbsp;Shannon C. Kelly ,&nbsp;Hyo-Jin Kim ,&nbsp;Brian J. DeBosch","doi":"10.1016/j.molmet.2025.102270","DOIUrl":"10.1016/j.molmet.2025.102270","url":null,"abstract":"<div><h3>Objectives</h3><div>Obesity is linked to metabolic disorders including type 2 diabetes, metabolic dysfunction-associated steatotic liver disease, and cardiovascular disease. Lifestyle interventions, such as time-restricted feeding (TRF), have proven to be effective for long-term weight management. The metabolic effects of TRF are closely associated with circadian clock function in the liver. We previously demonstrated that the circadian gene <em>Period 1</em> (<em>Per1</em>) mediates responses to acute fasting in both sexes. We therefore hypothesized that hepatocyte <em>Per1</em> contributes to the long-term adaptations to repeated fasting exposure in the form of TRF, and investigated its role in diet-induced obesity in both sexes.</div></div><div><h3>Methods</h3><div>Male and female mice with or without hepatocyte <em>Per1</em> (<em>Per1</em><sup>fl/fl</sup> and <em>Per1</em><sup>LKO</sup>) were subjected to either <em>ad libitum</em> feeding (ALF) or TRF restricted to the active phase (8 h/day).</div></div><div><h3>Results</h3><div>TRF attenuated Western diet-induced weight gain and peripheral and hepatic lipid accumulation, and improved heat production, metabolic substrate flexibility, and glucose homeostasis in <em>Per1</em><sup>fl/fl</sup> and <em>Per1</em><sup>LKO</sup> males. In contrast, hepatocyte <em>Per1</em> was required for TRF-induced improvements in energy expenditure and peripheral and hepatic lipid accumulation in females. Surprisingly, TRF failed to significantly attenuate diet-induced weight gain or glucose and insulin tolerance in females independent of genotype. Transcriptomic data revealed sex-specific transcriptional responses to TRF and to hepatocyte-specific <em>Per1</em> deletion. Specifically, genes involved in lipid metabolism were differentially regulated when comparing TRF-treated <em>Per1</em><sup>fl/fl</sup> and <em>Per1</em><sup>LKO</sup> female mice.</div></div><div><h3>Conclusions</h3><div>Hepatocyte <em>Per1</em> mediates the energy, lipid, and glucose homeostatic effects of TRF, and this regulation is almost completely sex-dependent.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"102 ","pages":"Article 102270"},"PeriodicalIF":6.6,"publicationDate":"2025-10-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145313248","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Adipocyte heparan sulfate determines type 2 diabetes susceptibility in mice via FGF1-Mediated glucose regulation 脂肪细胞硫酸肝素通过fgf1介导的葡萄糖调节决定小鼠2型糖尿病的易感性。
IF 6.6 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-08 DOI: 10.1016/j.molmet.2025.102267
Chung-Jui Yu , Ariane R. Pessentheiner , Sihao Liu , Sarah Wax , Marissa L. Maciej-Hulme , Chelsea D. Painter , Bastian Ramms , Daniel R. Sandoval , Anthony Quach , Natalie DeForest , G. Michelle Ducasa , Chiara Tognaccini , Caroline Labib , Norah Al-Azzam , Friederike Haumann , Greg Trieger , Patrick Secrest , Amit Majithia , Aaron C. Petrey , Kamil Godula , Philip L.S.M. Gordts
Obesity is the principal driver of insulin resistance, and lipodystrophy is also linked with insulin resistance, emphasizing the vital role of adipose tissue in glucose homeostasis. The quality of adipose tissue expansion is a critical determinant of insulin resistance predisposition, with individuals suffering from metabolic unhealthy adipose expansion exhibiting greater risk. Adipocytes are pivotal in orchestrating metabolic adjustments in response to nutrient intake and cell intrinsic factors that positively regulate these adjustments are key to prevent Type-2 diabetes. Employing unique genetic mouse models, we established the critical involvement of heparan sulfate (HS), a fundamental element of the adipocyte glycocalyx, in upholding glucose homeostasis during dietary stress. Genetic models that compromise adipocyte HS accelerate the development of high-fat diet-induced hyperglycemia and insulin resistance, independent of weight gain. Mechanistically, we show that perturbations in adipocyte HS disrupts endogenous FGF1 signaling, a key nutrient-sensitive effector. Furthermore, compromising adipocyte HS composition detrimentally impacts FGF1-FGFR1-mediated endocrinization, with no significant improvement observed in glucose homeostasis. Our data establish adipocyte HS composition as a determinant of Type 2 diabetes susceptibility and the critical dependency of the endogenous adipocyte FGF1 metabolic pathway on HS.
肥胖是胰岛素抵抗的主要驱动因素,脂肪营养不良也与胰岛素抵抗有关,强调脂肪组织在葡萄糖稳态中的重要作用。脂肪组织扩张的质量是胰岛素抵抗易感性的关键决定因素,患有代谢不健康脂肪扩张的个体表现出更大的风险。脂肪细胞是协调代谢调节以响应营养摄入的关键,细胞内在因子积极调节这些调节是预防2型糖尿病的关键。采用独特的遗传小鼠模型,我们建立了硫酸肝素(HS)的关键参与,脂肪细胞糖萼的基本元素,在饮食应激期间维持葡萄糖稳态。损害脂肪细胞HS的遗传模型加速了高脂肪饮食诱导的高血糖和胰岛素抵抗的发展,与体重增加无关。在机制上,我们发现脂肪细胞HS的扰动会破坏内源性FGF1信号,这是一种关键的营养敏感效应物。此外,脂肪细胞HS组成的降低会对fgf1 - fgfr1介导的内分泌产生不利影响,葡萄糖稳态没有明显改善。我们的数据证实了脂肪细胞HS组成是2型糖尿病易感性的决定因素,以及内源性脂肪细胞FGF1代谢途径对HS的关键依赖。
{"title":"Adipocyte heparan sulfate determines type 2 diabetes susceptibility in mice via FGF1-Mediated glucose regulation","authors":"Chung-Jui Yu ,&nbsp;Ariane R. Pessentheiner ,&nbsp;Sihao Liu ,&nbsp;Sarah Wax ,&nbsp;Marissa L. Maciej-Hulme ,&nbsp;Chelsea D. Painter ,&nbsp;Bastian Ramms ,&nbsp;Daniel R. Sandoval ,&nbsp;Anthony Quach ,&nbsp;Natalie DeForest ,&nbsp;G. Michelle Ducasa ,&nbsp;Chiara Tognaccini ,&nbsp;Caroline Labib ,&nbsp;Norah Al-Azzam ,&nbsp;Friederike Haumann ,&nbsp;Greg Trieger ,&nbsp;Patrick Secrest ,&nbsp;Amit Majithia ,&nbsp;Aaron C. Petrey ,&nbsp;Kamil Godula ,&nbsp;Philip L.S.M. Gordts","doi":"10.1016/j.molmet.2025.102267","DOIUrl":"10.1016/j.molmet.2025.102267","url":null,"abstract":"<div><div>Obesity is the principal driver of insulin resistance, and lipodystrophy is also linked with insulin resistance, emphasizing the vital role of adipose tissue in glucose homeostasis. The quality of adipose tissue expansion is a critical determinant of insulin resistance predisposition, with individuals suffering from metabolic unhealthy adipose expansion exhibiting greater risk. Adipocytes are pivotal in orchestrating metabolic adjustments in response to nutrient intake and cell intrinsic factors that positively regulate these adjustments are key to prevent Type-2 diabetes. Employing unique genetic mouse models, we established the critical involvement of heparan sulfate (HS), a fundamental element of the adipocyte glycocalyx, in upholding glucose homeostasis during dietary stress. Genetic models that compromise adipocyte HS accelerate the development of high-fat diet-induced hyperglycemia and insulin resistance, independent of weight gain. Mechanistically, we show that perturbations in adipocyte HS disrupts endogenous FGF1 signaling, a key nutrient-sensitive effector. Furthermore, compromising adipocyte HS composition detrimentally impacts FGF1-FGFR1-mediated endocrinization, with no significant improvement observed in glucose homeostasis. Our data establish adipocyte HS composition as a determinant of Type 2 diabetes susceptibility and the critical dependency of the endogenous adipocyte FGF1 metabolic pathway on HS.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"102 ","pages":"Article 102267"},"PeriodicalIF":6.6,"publicationDate":"2025-10-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145275255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isotype-selective roles of hepatic acetyl-CoA carboxylases in a mouse model of fatty liver disease 肝乙酰辅酶a羧化酶在脂肪肝小鼠模型中的同型选择作用
IF 6.6 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-04 DOI: 10.1016/j.molmet.2025.102264
Martina Beretta , Calum S. Vancuylenburg , Riya Shrestha , Ellen M. Olzomer , Brenna Osborne , Mingyan Zhou , Suri Zhang , Adam Hargreaves , Frances L. Byrne , Kyle L. Hoehn

Objectives

Acetyl-CoA carboxylase enzymes ACC1 and ACC2 promote liver fat storage. Accordingly, ACC inhibition represents a strategy to reverse fatty liver disease and related disorders. Human and rodent studies show that targeting both ACC isotypes can reverse some fatty liver phenotypes, but also result in unwanted metabolic phenotypes including hypertriglyceridemia. The objective of this study was to determine whether liver-selective genetic inhibition of ACC1 or ACC2 individually can reverse fatty liver disease phenotypes without adverse metabolic phenotypes in a mouse model of fatty liver disease.

Methods

Four genotypes of male C57BL/6J mice floxed for ACC1, ACC2, both ACC alleles, or no ACC alleles were fed an Amylin diet for 28 weeks to induce fatty liver disease. After 20 weeks of Amylin feeding, ACC genes were deleted in the liver by adeno-associated virus 8 (AAV8)-mediated Cre recombinase expression. Mice were metabolically phenotyped and liver disease was assessed by histopathology.

Results

Dual inhibition of ACC enzymes was necessary to achieve significant reversal of fatty liver disease and fibrosis; however, it also caused hypertriglyceridemia, weight gain, and glucose intolerance. ACC1 inhibition alone resulted in partial reversal of fatty liver disease phenotypes but drove all undesired metabolic phenotypes. In contrast, ACC2 inhibition alone had minimal effect on fatty liver, fibrosis, or metabolic phenotypes.

Conclusions

Our results indicate that complete inhibition of liver ACC activity is required to resolve fatty liver disease and fibrosis, with ACC1 inhibition being the dominant driver of unwanted metabolic dysregulation. Accordingly, selective inhibition of ACC2 with partial inhibition of ACC1 may represent a refined future approach to reverse fatty liver disease phenotypes while minimizing metabolic dysregulation.
目的:乙酰辅酶a羧化酶ACC1和ACC2促进肝脏脂肪储存。因此,ACC抑制是逆转脂肪肝疾病和相关疾病的一种策略。人类和啮齿动物的研究表明,靶向ACC同型可以逆转一些脂肪肝表型,但也会导致不需要的代谢表型,包括高甘油三酯血症。本研究的目的是确定在脂肪肝小鼠模型中,肝脏选择性基因抑制ACC1或ACC2是否能在不产生不良代谢表型的情况下逆转脂肪肝的表型。方法:采用四种基因型C57BL/6J雄性小鼠,分别饲喂ACC1、ACC2、ACC双等位基因和无ACC等位基因的胰淀素饲料,诱导脂肪肝28周。饲喂胰淀粉酶20周后,通过腺相关病毒8 (AAV8)介导的Cre重组酶表达,肝脏中ACC基因被删除。小鼠进行代谢表型分析,并通过组织病理学评估肝脏疾病。结果:双重抑制ACC酶对于实现脂肪肝疾病和纤维化的显著逆转是必要的;然而,它也会引起高甘油三酯血症、体重增加和葡萄糖耐受不良。单独抑制ACC1可部分逆转脂肪肝表型,但可驱动所有不希望的代谢表型。相比之下,单独抑制ACC2对脂肪肝、纤维化或代谢表型的影响很小。结论:我们的研究结果表明,完全抑制肝脏ACC活性是解决脂肪肝疾病和纤维化所必需的,而ACC1抑制是不必要的代谢失调的主要驱动因素。我们的研究结果表明,选择性抑制ACC2和部分抑制ACC1可能代表了一种改进的未来方法,可以逆转脂肪性肝病表型,同时最大限度地减少代谢失调。
{"title":"Isotype-selective roles of hepatic acetyl-CoA carboxylases in a mouse model of fatty liver disease","authors":"Martina Beretta ,&nbsp;Calum S. Vancuylenburg ,&nbsp;Riya Shrestha ,&nbsp;Ellen M. Olzomer ,&nbsp;Brenna Osborne ,&nbsp;Mingyan Zhou ,&nbsp;Suri Zhang ,&nbsp;Adam Hargreaves ,&nbsp;Frances L. Byrne ,&nbsp;Kyle L. Hoehn","doi":"10.1016/j.molmet.2025.102264","DOIUrl":"10.1016/j.molmet.2025.102264","url":null,"abstract":"<div><h3>Objectives</h3><div>Acetyl-CoA carboxylase enzymes ACC1 and ACC2 promote liver fat storage. Accordingly, ACC inhibition represents a strategy to reverse fatty liver disease and related disorders. Human and rodent studies show that targeting both ACC isotypes can reverse some fatty liver phenotypes, but also result in unwanted metabolic phenotypes including hypertriglyceridemia. The objective of this study was to determine whether liver-selective genetic inhibition of ACC1 or ACC2 individually can reverse fatty liver disease phenotypes without adverse metabolic phenotypes in a mouse model of fatty liver disease.</div></div><div><h3>Methods</h3><div>Four genotypes of male C57BL/6J mice floxed for ACC1, ACC2, both ACC alleles, or no ACC alleles were fed an Amylin diet for 28 weeks to induce fatty liver disease. After 20 weeks of Amylin feeding, ACC genes were deleted in the liver by adeno-associated virus 8 (AAV8)-mediated Cre recombinase expression. Mice were metabolically phenotyped and liver disease was assessed by histopathology.</div></div><div><h3>Results</h3><div>Dual inhibition of ACC enzymes was necessary to achieve significant reversal of fatty liver disease and fibrosis; however, it also caused hypertriglyceridemia, weight gain, and glucose intolerance. ACC1 inhibition alone resulted in partial reversal of fatty liver disease phenotypes but drove all undesired metabolic phenotypes. In contrast, ACC2 inhibition alone had minimal effect on fatty liver, fibrosis, or metabolic phenotypes.</div></div><div><h3>Conclusions</h3><div>Our results indicate that complete inhibition of liver ACC activity is required to resolve fatty liver disease and fibrosis, with ACC1 inhibition being the dominant driver of unwanted metabolic dysregulation. Accordingly, selective inhibition of ACC2 with partial inhibition of ACC1 may represent a refined future approach to reverse fatty liver disease phenotypes while minimizing metabolic dysregulation.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"102 ","pages":"Article 102264"},"PeriodicalIF":6.6,"publicationDate":"2025-10-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145233086","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Salivary extracellular vesicle-derived microRNAs are related to variances in parameters of obesity, taste and eating behaviour 唾液细胞外囊泡衍生的microrna与肥胖、味觉和饮食行为参数的差异有关。
IF 6.6 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-03 DOI: 10.1016/j.molmet.2025.102265
Kristin Röhrborn , Anne Hoffmann , Andrea Lorenz , Peter Kovacs , Tobias Hagemann , Paul Czechowski , Maria Sehm , Annette Horstmann , Michael Stumvoll , Matthias Blüher , Imke Schamarek , Kerstin Rohde-Zimmermann

Background

Extracellular vesicles (EVs), conveyors of microRNAs, have recently been linked to obesity. As taste is a potent driver of eating behaviour and food intake, it's connection to EVs is of increasing interest. This study aimed at deciphering the salivary EV-microRNA profile in relation to taste perception and metabolic pathways of obesity.

Methods

Small RNA sequencing was performed on isolated salivary EVs of 90 participants from the Obese-Taste-Bud study. Pathway enrichment and association analyses were conducted to link identified microRNAs to taste recognition, eating behaviour, food intake and various anthropometric-, metabolic- and oral health parameter.

Results

The 626 identified microRNAs clustered into pathways related to energy regulation, obesity and diabetes, cell signaling and taste perception. The top three enriched microRNAs are miR-1246, miR-1290 and miR-148a-3p which showed significant associations with fasting blood glucose and cholesterol level, anthropometrics and blood pressure (p < 0.05). Additionally, these microRNAs associate with trait eating behaviour (p < 0.05). Several other microRNAs were linked to differences in taste recognition scores and are further related to parameters of glucose metabolism and periodontal health, salivary insulin level or food intake (p < 0.05).

Conclusions

This study, one of the largest on salivary EVs, supports an interrelation of EV's microRNA load with metabolism, eating behaviour and taste recognition offering potential targets for obesity intervention.
背景:细胞外囊泡(ev)是microrna的载体,最近被认为与肥胖有关。由于味觉是饮食行为和食物摄入的有力驱动因素,它与电动汽车的联系越来越受到关注。本研究旨在解读与味觉感知和肥胖代谢途径相关的唾液EV-microRNA谱。方法:对来自肥胖-味蕾研究的90名参与者的分离唾液EVs进行小RNA测序。研究人员进行了途径富集和关联分析,将鉴定出的microrna与味觉识别、饮食行为、食物摄入以及各种人体测量、代谢和口腔健康参数联系起来。结果:626个鉴定的microrna聚集在能量调节、肥胖和糖尿病、细胞信号传导和味觉感知相关的途径中。前三位富集的microRNA分别是miR-1246、miR-1290和miR-148a-3p,它们与空腹血糖和胆固醇水平、人体测量学和血压有显著相关性(结论:本研究是对唾液EV的最大研究之一,支持EV的microRNA负荷与代谢、饮食行为和味觉识别之间的相互关系,为肥胖干预提供了潜在的靶点。
{"title":"Salivary extracellular vesicle-derived microRNAs are related to variances in parameters of obesity, taste and eating behaviour","authors":"Kristin Röhrborn ,&nbsp;Anne Hoffmann ,&nbsp;Andrea Lorenz ,&nbsp;Peter Kovacs ,&nbsp;Tobias Hagemann ,&nbsp;Paul Czechowski ,&nbsp;Maria Sehm ,&nbsp;Annette Horstmann ,&nbsp;Michael Stumvoll ,&nbsp;Matthias Blüher ,&nbsp;Imke Schamarek ,&nbsp;Kerstin Rohde-Zimmermann","doi":"10.1016/j.molmet.2025.102265","DOIUrl":"10.1016/j.molmet.2025.102265","url":null,"abstract":"<div><h3>Background</h3><div>Extracellular vesicles (EVs), conveyors of microRNAs, have recently been linked to obesity. As taste is a potent driver of eating behaviour and food intake, it's connection to EVs is of increasing interest. This study aimed at deciphering the salivary EV-microRNA profile in relation to taste perception and metabolic pathways of obesity.</div></div><div><h3>Methods</h3><div>Small RNA sequencing was performed on isolated salivary EVs of 90 participants from the Obese-Taste-Bud study. Pathway enrichment and association analyses were conducted to link identified microRNAs to taste recognition, eating behaviour, food intake and various anthropometric-, metabolic- and oral health parameter.</div></div><div><h3>Results</h3><div>The 626 identified microRNAs clustered into pathways related to energy regulation, obesity and diabetes, cell signaling and taste perception. The top three enriched microRNAs are miR-1246, miR-1290 and miR-148a-3p which showed significant associations with fasting blood glucose and cholesterol level, anthropometrics and blood pressure (p &lt; 0.05). Additionally, these microRNAs associate with trait eating behaviour (p &lt; 0.05). Several other microRNAs were linked to differences in taste recognition scores and are further related to parameters of glucose metabolism and periodontal health, salivary insulin level or food intake (p &lt; 0.05).</div></div><div><h3>Conclusions</h3><div>This study, one of the largest on salivary EVs, supports an interrelation of EV's microRNA load with metabolism, eating behaviour and taste recognition offering potential targets for obesity intervention.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"102 ","pages":"Article 102265"},"PeriodicalIF":6.6,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145233021","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
TERT expression attenuates metabolic disorders in obese mice by promoting adipose stem and progenitor cell expansion and differentiation TERT表达通过促进脂肪干细胞和祖细胞的扩增和分化来减轻肥胖小鼠的代谢紊乱。
IF 6.6 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-03 DOI: 10.1016/j.molmet.2025.102262
Laura Braud , Manuel Bernabe , Julien Vernerey , Antonio M.A. Miranda , Andrea Dominguez , Dmitri Churikov , Manon Richaud , Frédéric Jourquin , Liam Mc Allan , Christophe Lachaud , Jesus Gil , Will Scott , Vincent Géli

Background and aims

Adipose tissue (AT) senescence, induced by obesity or aging, leads to a reduced capacity for tissue remodeling and a chronic pro-inflammatory state, which leads to the onset of metabolic pathologies. Cellular senescence is triggered by various stresses, in particular excessive shortening of telomeres, which activates the p21 pathway and leads to the arrest of the cell cycle. We used the mouse model p21+/Tert expressing TERT from the Cdkn1a locus to investigate whether counteracting telomere shortening by telomerase (TERT) specifically in pre-senescent cells could improve obesity-induced metabolic disorders.

Results

Our study demonstrates that conditional expression of TERT reduces insulin-resistance and glucose intolerance associated with obesity. In AT, this is accompanied by a decrease in the number of senescent p21-positive cells, very short telomeres, and oxidative DNA damage. Single nucleus RNA-seq data reveal TERT expression attenuates senescence induced by HFD in particular in adipose stem and progenitor cells (ASPC). We demonstrate that ASPC expansion and differentiation are promoted in p21+/Tert obese mice, thereby improving AT plasticity. Furthermore, we show that TERT expression enhances mitochondrial function and alleviates oxidative stress in ASPC. This process contributes to the AT hyperplasia with increased number of adipocytes which has been shown to have a protective effect against obesity-associated metabolic disorders.

Conclusions

These results underscore TERT's role in mitigating obesity-related metabolic dysfunction. Conditional TERT expression may therefore represent as a promising therapeutic strategy for obesity-associated metabolic disorders.
背景和目的:脂肪组织(AT)衰老,由肥胖或衰老引起,导致组织重塑能力降低和慢性促炎状态,从而导致代谢病理的发生。细胞衰老是由各种压力触发的,尤其是端粒的过度缩短,它激活了p21途径,导致细胞周期的停滞。我们使用表达Cdkn1a基因座Tert的p21+/Tert小鼠模型来研究在衰老前细胞中,通过端粒酶(Tert)特异性地对抗端粒缩短是否可以改善肥胖诱导的代谢紊乱。结果:我们的研究表明TERT的条件表达可以减少与肥胖相关的胰岛素抵抗和葡萄糖耐受不良。在AT中,这伴随着衰老p21阳性细胞数量的减少,端粒非常短,以及氧化性DNA损伤。单核RNA-seq数据显示,TERT表达可减缓HFD诱导的衰老,特别是在脂肪干细胞和祖细胞(ASPC)中。我们发现p21+/Tert肥胖小鼠的ASPC扩展和分化被促进,从而改善了AT的可塑性。此外,我们发现TERT的表达增强了ASPC的线粒体功能并减轻了氧化应激。这一过程导致AT增生,脂肪细胞数量增加,这已被证明对肥胖相关代谢紊乱具有保护作用。结论:这些结果强调了TERT在减轻肥胖相关代谢功能障碍中的作用。因此,条件TERT表达可能是一种有希望的治疗肥胖相关代谢紊乱的策略。
{"title":"TERT expression attenuates metabolic disorders in obese mice by promoting adipose stem and progenitor cell expansion and differentiation","authors":"Laura Braud ,&nbsp;Manuel Bernabe ,&nbsp;Julien Vernerey ,&nbsp;Antonio M.A. Miranda ,&nbsp;Andrea Dominguez ,&nbsp;Dmitri Churikov ,&nbsp;Manon Richaud ,&nbsp;Frédéric Jourquin ,&nbsp;Liam Mc Allan ,&nbsp;Christophe Lachaud ,&nbsp;Jesus Gil ,&nbsp;Will Scott ,&nbsp;Vincent Géli","doi":"10.1016/j.molmet.2025.102262","DOIUrl":"10.1016/j.molmet.2025.102262","url":null,"abstract":"<div><h3>Background and aims</h3><div>Adipose tissue (AT) senescence, induced by obesity or aging, leads to a reduced capacity for tissue remodeling and a chronic pro-inflammatory state, which leads to the onset of metabolic pathologies. Cellular senescence is triggered by various stresses, in particular excessive shortening of telomeres, which activates the p21 pathway and leads to the arrest of the cell cycle. We used the mouse model p21<sup>+/Tert</sup> expressing TERT from the Cdkn1a locus to investigate whether counteracting telomere shortening by telomerase (TERT) specifically in pre-senescent cells could improve obesity-induced metabolic disorders.</div></div><div><h3>Results</h3><div>Our study demonstrates that conditional expression of TERT reduces insulin-resistance and glucose intolerance associated with obesity. In AT, this is accompanied by a decrease in the number of senescent p21-positive cells, very short telomeres, and oxidative DNA damage. Single nucleus RNA-seq data reveal TERT expression attenuates senescence induced by HFD in particular in adipose stem and progenitor cells (ASPC). We demonstrate that ASPC expansion and differentiation are promoted in p21<sup>+/Tert</sup> obese mice, thereby improving AT plasticity. Furthermore, we show that TERT expression enhances mitochondrial function and alleviates oxidative stress in ASPC. This process contributes to the AT hyperplasia with increased number of adipocytes which has been shown to have a protective effect against obesity-associated metabolic disorders.</div></div><div><h3>Conclusions</h3><div>These results underscore TERT's role in mitigating obesity-related metabolic dysfunction. Conditional TERT expression may therefore represent as a promising therapeutic strategy for obesity-associated metabolic disorders.</div></div>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":"102 ","pages":"Article 102262"},"PeriodicalIF":6.6,"publicationDate":"2025-10-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145233108","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oxytocin neurons in the paraventricular and supraoptic hypothalamic nuclei bidirectionally modulate food intake. 脑室旁核和下丘脑视上核中的催产素神经元双向调节食物摄入。
IF 6.6 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-01 Epub Date: 2025-07-23 DOI: 10.1016/j.molmet.2025.102220
Jessica J Rea, Clarissa M Liu, Anna M R Hayes, Rita Ohan, Grace M Schwartz, Alexander G Bashaw, Molly E Klug, Lea Decarie-Spain, Yedam Park, Alicia E Kao, Valery Grinevich, Scott E Kanoski

Objectives: Oxytocin (OT) is a neuropeptide produced in the paraventricular (PVH) and supraoptic (SON) nuclei of the hypothalamus. Either peripheral or central OT administration reduces food intake through reductions in meal size. However, pharmacological approaches do not differentiate whether OT's influence on food intake is mediated by OT neurons located in the PVH vs. the SON. Here we address this gap using both gain- and loss-of-function approaches targeting OT neurons.

Methods: OT neuron-specific designer receptors exclusively activated by designer drugs (DREADDs) were targeted in either the PVH or SON in rats, thus allowing for evaluation of caloric intake following selective activation of OT neurons separately in each nucleus. To examine the physiological role of distinct OT neuron populations in eating behavior, a viral-mediated approach was used to silence synaptic transmission of OT neurons separately in either the PVH or SON.

Results: DREADDs-mediated excitation of PVH OT neurons reduced consumption of standard chow via reductions in meal size. On the contrary, SON OT neuron activation had the opposite effect by increasing standard chow consumption. Consistent with these opposing outcomes, activation of PVH and SON OT neurons simultaneously had minimal effects on food intake. Additional results from chronic loss-of-function experiments reveal that PVH OT neuron silencing significantly increased consumption of a high fat and high sugar diet by increasing meal size whereas SON OT neuron silencing reduced chow consumption by decreasing meal size.

Conclusions: Collectively these findings suggest that PVH and SON OT neurons differentially modulate food intake by either reducing or increasing caloric consumption, respectively.

催产素(OT)是一种产生于下丘脑室旁核(PVH)和视上核(SON)的神经肽。外周或中央OT管理通过减少餐量来减少食物摄入。然而,药理学方法并不能区分OT对食物摄入的影响是由位于PVH还是SON的OT神经元介导的。为了解决这个问题,我们针对大鼠PVH或SON中专为设计药物(DREADDs)激活的OT神经元特异性设计受体,从而可以评估每个核中选择性激活OT神经元后的热量摄入。结果显示,由dreadds介导的PVH - OT神经元的兴奋通过减少餐量来减少标准食物的消耗。相反,SON - OT神经元的激活通过增加标准食物摄入量而产生相反的效果。与这些相反的结果一致,PVH和SON - OT神经元同时激活对食物摄入的影响很小。为了进一步研究不同的OT神经元群体在进食行为中的生理作用,研究人员采用病毒介导的方法分别沉默PVH或SON中OT神经元的突触传递。这些研究的结果表明,PVH OT神经元沉默通过增加餐量来显著增加高脂肪和高糖饮食的消耗,而SON OT神经元沉默通过减少餐量来减少食物消耗。总的来说,这些发现表明PVH和SON - OT神经元分别通过减少或增加热量消耗来调节食物摄入。
{"title":"Oxytocin neurons in the paraventricular and supraoptic hypothalamic nuclei bidirectionally modulate food intake.","authors":"Jessica J Rea, Clarissa M Liu, Anna M R Hayes, Rita Ohan, Grace M Schwartz, Alexander G Bashaw, Molly E Klug, Lea Decarie-Spain, Yedam Park, Alicia E Kao, Valery Grinevich, Scott E Kanoski","doi":"10.1016/j.molmet.2025.102220","DOIUrl":"10.1016/j.molmet.2025.102220","url":null,"abstract":"<p><strong>Objectives: </strong>Oxytocin (OT) is a neuropeptide produced in the paraventricular (PVH) and supraoptic (SON) nuclei of the hypothalamus. Either peripheral or central OT administration reduces food intake through reductions in meal size. However, pharmacological approaches do not differentiate whether OT's influence on food intake is mediated by OT neurons located in the PVH vs. the SON. Here we address this gap using both gain- and loss-of-function approaches targeting OT neurons.</p><p><strong>Methods: </strong>OT neuron-specific designer receptors exclusively activated by designer drugs (DREADDs) were targeted in either the PVH or SON in rats, thus allowing for evaluation of caloric intake following selective activation of OT neurons separately in each nucleus. To examine the physiological role of distinct OT neuron populations in eating behavior, a viral-mediated approach was used to silence synaptic transmission of OT neurons separately in either the PVH or SON.</p><p><strong>Results: </strong>DREADDs-mediated excitation of PVH OT neurons reduced consumption of standard chow via reductions in meal size. On the contrary, SON OT neuron activation had the opposite effect by increasing standard chow consumption. Consistent with these opposing outcomes, activation of PVH and SON OT neurons simultaneously had minimal effects on food intake. Additional results from chronic loss-of-function experiments reveal that PVH OT neuron silencing significantly increased consumption of a high fat and high sugar diet by increasing meal size whereas SON OT neuron silencing reduced chow consumption by decreasing meal size.</p><p><strong>Conclusions: </strong>Collectively these findings suggest that PVH and SON OT neurons differentially modulate food intake by either reducing or increasing caloric consumption, respectively.</p>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":" ","pages":"102220"},"PeriodicalIF":6.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12356352/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144718195","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Regulation of hedonic feeding rhythms by circadian clocks in leptin-receptive neurons. 瘦素接受神经元的生物钟对享乐性进食节律的调节。
IF 6.6 2区 医学 Q1 ENDOCRINOLOGY & METABOLISM Pub Date : 2025-10-01 Epub Date: 2025-07-24 DOI: 10.1016/j.molmet.2025.102221
Jazmin Osorio-Mendoza, Jana-Thabea Kiehn, Sarah Stenger, Keno O Heinen, Laura Griewahn, Christiane E Koch, Undine Haferkamp, Violetta Pilorz, Johanna L Barclay, Parth Joshi, Lisbeth Harder, Olaf Jöhren, Peter Kühnen, Gregor Eichele, Henrik Oster

Objective: The circadian clock anticipates daily repetitive events to adapt physiological processes. In mammals, the circadian system consists of a master clock in the suprachiasmatic nucleus (SCN), which synchronizes subordinate tissue clocks, including extra-SCN central nervous system (CNS) clocks involved in functions such as sleep and appetite regulation. Appetite is controlled by both homeostatic and non-homeostatic (hedonic) circuits. Homeostatic appetite addresses energy needs, while hedonic feeding targets cravings for palatable, calorie-dense foods. The adipokine leptin is a major appetite regulator, interacting with the circadian clock. Although leptin's role in satiation through its action in the mediobasal hypothalamus (MBH) is well established, its involvement in the circadian regulation of feeding remains poorly understood. We hypothesized that circadian gating of leptin signaling in the CNS controls homeostatic and hedonic appetite across the day.

Methods: We analyzed food intake rhythms in mice with a loss of leptin (ob/ob mice) or clock function (Per1/2 or Bmal1 KO) and in mice with specific disruption of leptin circadian gating in the CNS (ObRb.Bmal1).

Results: We found that in leptin-deficient mice hedonic appetite increases specifically in the early rest phase. In contrast, clock-deficient Per1/2 mutant mice exhibit blunted rhythms in both hedonic and homeostatic appetite control. Finally, when clock function is disrupted in leptin-sensitive neurons only, mice display a lower sensitivity to palatable food, along with reduced initial weight gain and adipose hypertrophy under obesogenic diet conditions.

Conclusions: Our data describe a local clock-controlled central leptin gating mechanism that modulates hedonic food intake rhythms and impacts metabolic homeostasis.

生物钟预测每天重复的事件以适应生理过程。在哺乳动物中,昼夜节律系统由位于视交叉上核(SCN)的主时钟组成,该时钟与下属组织时钟同步,包括参与睡眠和食欲调节等功能的SCN外中枢神经系统(CNS)时钟。食欲是由稳态和非稳态(享乐)电路控制的。稳态食欲解决的是能量需求,而享乐性进食针对的是对美味、高热量食物的渴望。脂肪因子瘦素是一种主要的食欲调节剂,与生物钟相互作用。尽管瘦素通过其在中基底下丘脑(MBH)中的作用在饱腹感中所起的作用已经得到了很好的证实,但它在进食昼夜节律调节中的作用仍然知之甚少。我们假设中枢神经系统中瘦素信号的昼夜节律门控控制着一天中的稳态和享乐性食欲。为了验证这一点,我们分析了瘦素缺失小鼠(ob/ob小鼠)或时钟功能缺失小鼠(Per1/2或Bmal1 KO)以及瘦素昼夜节律门控在中枢神经系统中特异性破坏的小鼠(ObRb.Bmal1)的食物摄入节律。我们发现在瘦素缺乏的小鼠中,享乐性食欲在休息早期特别增加。相比之下,生物钟缺陷的Per1/2突变小鼠在享乐和自我平衡食欲控制方面都表现出迟钝的节律。最后,当生物钟功能仅在瘦素敏感神经元中被破坏时,小鼠对美味食物的敏感性降低,同时在致肥性饮食条件下,初始体重增加和脂肪肥大也减少。总之,我们的数据描述了一种局部时钟控制的中央瘦素门控机制,该机制调节享乐性食物摄入节律并影响代谢稳态。
{"title":"Regulation of hedonic feeding rhythms by circadian clocks in leptin-receptive neurons.","authors":"Jazmin Osorio-Mendoza, Jana-Thabea Kiehn, Sarah Stenger, Keno O Heinen, Laura Griewahn, Christiane E Koch, Undine Haferkamp, Violetta Pilorz, Johanna L Barclay, Parth Joshi, Lisbeth Harder, Olaf Jöhren, Peter Kühnen, Gregor Eichele, Henrik Oster","doi":"10.1016/j.molmet.2025.102221","DOIUrl":"10.1016/j.molmet.2025.102221","url":null,"abstract":"<p><strong>Objective: </strong>The circadian clock anticipates daily repetitive events to adapt physiological processes. In mammals, the circadian system consists of a master clock in the suprachiasmatic nucleus (SCN), which synchronizes subordinate tissue clocks, including extra-SCN central nervous system (CNS) clocks involved in functions such as sleep and appetite regulation. Appetite is controlled by both homeostatic and non-homeostatic (hedonic) circuits. Homeostatic appetite addresses energy needs, while hedonic feeding targets cravings for palatable, calorie-dense foods. The adipokine leptin is a major appetite regulator, interacting with the circadian clock. Although leptin's role in satiation through its action in the mediobasal hypothalamus (MBH) is well established, its involvement in the circadian regulation of feeding remains poorly understood. We hypothesized that circadian gating of leptin signaling in the CNS controls homeostatic and hedonic appetite across the day.</p><p><strong>Methods: </strong>We analyzed food intake rhythms in mice with a loss of leptin (ob/ob mice) or clock function (Per1/2 or Bmal1 KO) and in mice with specific disruption of leptin circadian gating in the CNS (ObRb.Bmal1).</p><p><strong>Results: </strong>We found that in leptin-deficient mice hedonic appetite increases specifically in the early rest phase. In contrast, clock-deficient Per1/2 mutant mice exhibit blunted rhythms in both hedonic and homeostatic appetite control. Finally, when clock function is disrupted in leptin-sensitive neurons only, mice display a lower sensitivity to palatable food, along with reduced initial weight gain and adipose hypertrophy under obesogenic diet conditions.</p><p><strong>Conclusions: </strong>Our data describe a local clock-controlled central leptin gating mechanism that modulates hedonic food intake rhythms and impacts metabolic homeostasis.</p>","PeriodicalId":18765,"journal":{"name":"Molecular Metabolism","volume":" ","pages":"102221"},"PeriodicalIF":6.6,"publicationDate":"2025-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12356030/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144718196","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Molecular Metabolism
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1